Gameto Partners with IVFAustralia for Advanced IVF Solutions
Gameto, a pioneering women's health biotechnology company, has teamed up with IVFAustralia, a respected IVF clinic network under the Virtus Health umbrella. This collaboration aims to provide Fertilo, Gameto's revolutionary product, to patients at selected IVFA clinics. It's noteworthy that Virtus Health stands tall as one of the top five assisted reproductive service providers globally.
Understanding Fertilo: A Breakthrough in Reproductive Health
Fertilo, an innovative solution derived from induced pluripotent stem cells (iPSC), allows for egg maturation outside the human body. This advancement minimizes hormonal stimulation cycles traditionally lasting between 10 to 14 days. By recreating the natural egg maturation process within a lab environment, Fertilo significantly reduces the necessary hormone injections by 80%, thereby shortening the overall IVF process and minimizing side effects during egg freezing.
Expertise Driving Change at IVFAustralia
Leading the integration of Fertilo at the IVFA clinics are Dr. Gavin Sacks and Dr. Cheryl Phua, both esteemed fertility specialists in Australia. Dr. Sacks serves as the Clinical Director of the Alexandria and Bondi Clinics, while also contributing his expertise as an Associate Professor at UNSW. He is celebrated for his pioneering research regarding the immune system's impact on recurrent miscarriage and IVF methodologies. His acclaimed “Bondi Protocol,” addressing implantation failures, has gained traction among specialists across the nation.
Dr. Gavin Sacks on Fertilo's Role
Commenting on this exciting venture, Dr. Sacks expressed, "I am thrilled to be leading the usage of Fertilo in our clinics at IVFA/Virtus. My career as a fertility specialist has always focused on innovative approaches to enhance the IVF experience for patients. Collaborating with the Gameto team to introduce iPSCs in IVF is a thrilling endeavor that holds great promise for improved patient outcomes."
Collaboration and Expertise Expanding Horizons
Working alongside Dr. Sacks is Dr. Tammie Roy, who has recently joined Gameto after a commendable 15-year tenure with Genea, another leading fertility clinic in Australia. Dr. Roy has led the development and commercialization of cutting-edge medical devices at Genea Biomedx, including an automated vitrification instrument that has transformed embryo and oocyte preservation and advanced incubator systems that boosted IVF pregnancy rates.
Insight from Gameto's Leadership
Gameto's CEO and Co-founder, Dr. Dina Radenkovic, shared her enthusiasm, stating, "Working with Dr. Gavin Sacks and the IVFA team fills us with excitement and anticipation. Australia has consistently been at the forefront of IVF advancements, and our partnership aims to extend access to Fertilo to patients around the world, starting from one of the most reputable fertility networks in Australia."
Global Reach and Future Availability
With its recent expansion, Fertilo is now accessible in four countries. In the U.S., the company is gearing up for Phase 3 clinical trials, showcasing their commitment to enhancing reproductive health on a broader scale.
Patients interested in Fertilo at IVFAustralia can directly reach out to the clinic to register their interest and check eligibility. Treatment will be administered by renowned specialists Dr. Gavin Sacks or Dr. Cheryl Phua.
About Gameto
Gameto is a forward-thinking biotechnology company focused on creating impactful solutions for women's health, particularly in the realm of infertility. The team is composed of seasoned professionals who are dedicated to reshaping the landscape of reproductive health, ensuring that women receive the utmost support throughout their reproductive journeys. With Fertilo, Gameto aspires to revolutionize IVF and egg freezing by making it safer, shorter, and more accessible while significantly reducing the number of hormonal injections required, by allowing for the maturing of eggs outside the body.
About IVFAustralia and Virtus Health
IVFAustralia, as part of the extensive Virtus Health network, stands as a leading entity in fertility care in Australia. The network prides itself on offering exceptional services designed to guide individuals and couples on their journey to parenthood. With state-of-the-art facilities and a compassionate approach, IVF Australia embodies a blend of innovative technology and patient-centered care, ensuring the best possible outcomes. As a member of one of the largest assisted reproductive service organizations in the world, IVF Australia benefits from an expansive network of research, innovation, and expertise, solidifying its reputation as a trusted leader in this vital field.
Frequently Asked Questions
What is Gameto's partnership with IVFAustralia about?
Gameto has partnered with IVFAustralia to offer its innovative Fertilo solution at select IVF clinics, aiming to enhance the IVF experience for patients.
What is Fertilo?
Fertilo is a product designed to mature eggs outside the body, significantly reducing the need for hormonal injections in IVF, making the process safer and shorter for patients.
Who are the leading specialists at IVFAustralia?
Dr. Gavin Sacks and Dr. Cheryl Phua are leading the integration of Fertilo in the clinics, both recognized experts in the field of fertility.
How many countries is Fertilo available in?
Fertilo is currently available in four countries, with plans for further expansion and Phase 3 trials in the U.S.
How can patients get involved with Fertilo in Australia?
Patients interested in the Fertilo treatment can contact IVFAustralia clinics to learn more about eligibility and the registration process.
